NOVNEE:

CHF125.02

-1.29%

Novartis AG

CHF as of Aug 3, 2026 | SIX - Swiss Exchange

Company Profile

1-Year Price Evolution & Moving Averages

1-Year: +31.32%

Multi-timeframe price chart with technical indicators - Swiss franc (CHF)

Company Description

Company Profile

Novartis AG develops and markets prescription medicines, including innovative and generic treatments, for cardiovascular, immunological, neurological, oncological, renal, and metabolic conditions.

Switzerland Healthcare Drug Manufacturers—General Swiss Healthcare Swiss Drug Manufacturers—General

Risk & Valuation

as of Aug. 1, 2026

Beta	0.50
Trailing PE	23.26
Forward PE	15.82

Stock Data

Open	CHF127.40
High	CHF127.68
Low	CHF124.76
Close	CHF125.02
Volume	130,250
Previous Close	CHF126.66
1-Day Change	-1.64
1-Year Change	+29.82
Average Daily Volume	166,161
52-Week High	CHF131.14
52-Week Low	CHF92.48

Disclaimer

All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!

Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.

Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.

Please conduct your own due diligence to verify insights.